Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by Bernie1234on Jan 08, 2020 9:14am

67 Views

Post# 30529776

Serious thought

Can you imagine waking up every day, creating/changing your screenname, copy and pasting your 20 posts from yesterday, posting them to a web forum where no ones cares, repeat it everyday for months, and wait for someone to reply so they can attack them and have everyone else wonder what the hell is wrong with you. All this just to hope to be right some day, so I can tell everyone that "I told you so".

I would seek some Serious help to figure out if there is more meaning to my life.

Bullboard Posts

One of the strongest contenders to lead Canada’s cannabis market